Krt6a-positive mammary epithelial progenitors are not at increased vulnerability to tumorigenesis initiated by ErbB2.

by Kimberly R Holloway, Vidya C Sinha, Michael J Toneff, Wen Bu, Susan G Hilsenbeck, Yi Li
Published 2015-01-01

Correction: Prevention of Hypovolemic Circulatory Collapse by IL-6 Activated Stat3

by Jeffrey A. Alten, Ana Moran, Anna I. Tsimelzon, Mary-Ann A. Mastrangelo, Susan G. Hilsenbeck, Valeria Poli, David J. Tweardy
Published 2008-01-01

Prevention of hypovolemic circulatory collapse by IL-6 activated Stat3.

by Jeffrey A Alten, Ana Moran, Anna I Tsimelzon, Mary-Ann A Mastrangelo, Susan G Hilsenbeck, Valeria Poli, David J Tweardy
Published 2008-02-01

Correction: Prevention of Hypovolemic Circulatory Collapse by IL-6 Activated Stat3.

by Jeffrey A. Alten, Ana Moran, Anna I. Tsimelzon, Mary-Ann A. Mastrangelo, Susan G. Hilsenbeck, Valeria Poli, David J. Tweardy
Published 2008-01-01

Correction: Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model

by Bhuvanesh Dave, Melissa D. Landis, Lacey E. Dobrolecki, Meng-Fen Wu, Xiaomei Zhang, Thomas F. Westbrook, Susan G. Hilsenbeck, Dan Liu, Michael T. Lewis, David J. Tweardy, Jenny C. Chang
Published 2012-01-01

Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model.

by Bhuvanesh Dave, Melissa D Landis, David J Tweardy, Jenny C Chang, Lacey E Dobrolecki, Meng-Fen Wu, Xiaomei Zhang, Thomas F Westbrook, Susan G Hilsenbeck, Dan Liu, Michael T Lewis
Published 2012-01-01

Correction: Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model.

by Bhuvanesh Dave, Melissa D. Landis, Lacey E. Dobrolecki, Meng-Fen Wu, Xiaomei Zhang, Thomas F. Westbrook, Susan G. Hilsenbeck, Dan Liu, Michael T. Lewis, David J. Tweardy, Jenny C. Chang
Published 2012-01-01

CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT

by Arindam Chaudhury, Shebna Cheema, Joseph M. Fachini, Natee Kongchan, Guojun Lu, Lukas M. Simon, Tao Wang, Sufeng Mao, Daniel G. Rosen, Michael M. Ittmann, Susan G. Hilsenbeck, Chad A. Shaw, Joel R. Neilson
Published 2016-11-01

Publisher Correction: EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells

by Deepika Neelakantan, Hengbo Zhou, Michael U. J. Oliphant, Xiaomei Zhang, Lukas M. Simon, David M. Henke, Chad A. Shaw, Meng-Fen Wu, Susan G. Hilsenbeck, Lisa D. White, Michael T. Lewis, Heide L. Ford
Published 2018-11-01

EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells

by Deepika Neelakantan, Hengbo Zhou, Michael U. J. Oliphant, Xiaomei Zhang, Lukas M. Simon, David M. Henke, Chad A. Shaw, Meng-Fen Wu, Susan G. Hilsenbeck, Lisa D. White, Michael T. Lewis, Heide L. Ford
Published 2017-06-01

Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled tri...

by Jane R. Montealegre, Matthew L. Anderson, Susan G. Hilsenbeck, Elizabeth Y. Chiao, Scott B. Cantor, Susan L. Parker, Maria Daheri, Shaun Bulsara, Betsy Escobar, Ashish A. Deshmukh, Maria L. Jibaja-Weiss, Mohammed Zare, Michael E. Scheurer
Published 2020-10-01

Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation

by Ze-Yi Zheng, Lin Tian, Wen Bu, Cheng Fan, Xia Gao, Hai Wang, Yi-Hua Liao, Yi Li, Michael T. Lewis, Dean Edwards, Thomas P. Zwaka, Susan G. Hilsenbeck, Daniel Medina, Charles M. Perou, Chad J. Creighton, Xiang H.-F. Zhang, Eric C. Chang
Published 2015-07-01

Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy

by Svasti Haricharan, Jie Dong, Sarah Hein, Jay P Reddy, Zhijun Du, Michael Toneff, Kimberly Holloway, Susan G Hilsenbeck, Shixia Huang, Rachel Atkinson, Wendy Woodward, Sonali Jindal, Virginia F Borges, Carolina Gutierrez, Hong Zhang, Pepper J Schedin, C Kent Osborne, David J Tweardy, Yi Li
Published 2013-12-01

Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models

by Jamunarani Veeraraghavan, Carolina Gutierrez, Vidyalakshmi Sethunath, Sepideh Mehravaran, Mario Giuliano, Martin J. Shea, Tamika Mitchell, Tao Wang, Sarmistha Nanda, Resel Pereira, Robert Davis, Kristina Goutsouliak, Lanfang Qin, Carmine De Angelis, Irmina Diala, Alshad S. Lalani, Chandandeep Nagi, Susan G. Hilsenbeck, Mothaffar F. Rimawi, C. Kent Osborne, Rachel Schiff
Published 2021-05-01

The Oncogenic STP Axis Promotes Triple-Negative Breast Cancer via Degradation of the REST Tumor Suppressor

by Kristen L. Karlin, Gourish Mondal, Jessica K. Hartman, Siddhartha Tyagi, Sarah J. Kurley, Chris S. Bland, Tiffany Y.T. Hsu, Alexander Renwick, Justin E. Fang, Ilenia Migliaccio, Celetta Callaway, Amritha Nair, Rocio Dominguez-Vidana, Don X. Nguyen, C. Kent Osborne, Rachel Schiff, Li-Yuan Yu-Lee, Sung Y. Jung, Dean P. Edwards, Susan G. Hilsenbeck, Jeffrey M. Rosen, Xiang H.-F. Zhang, Chad A. Shaw, Fergus J. Couch, Thomas F. Westbrook
Published 2014-11-01